The Paradox of Heme Oxygenase 1: From Cellular Defense to a Tug of War between Cancer Promotion and Prevention
Source abstract
Abstract
Abstract The Hmox1 enzyme, which is the inducible enzyme among the Hmoxs, catalyzes the first and rate‐limiting step in the heme degradation pathway, generating three byproducts, namely, carbon monoxide, free iron, and biliverdin. These byproducts can affect an array of biological processes; hence, Hmox1 modulates multiple metabolic processes. Along with the degradation of cytotoxic heme, Hmox1 provides protection against inflammation, apoptosis, and oxidative stress. It also ameliorates tissue injury, maintains iron homeostasis, and supports embryonic survival. Initially, different studies labeled it as an active cancer‐assisting agent; however, multiple recent studies have shown that it also deters cancer progression. Hence, this review first looks into the traditional role of Hmox1 and various Hmox1 inducers. Second, there are multiple links between Hmox1 and different types of cancer, including how it acts as a promoter or plays an antitumor role in different or even the same cancers. On the basis of the available data, the work proposes a few speculations to explain this dual role of Hmox1 in cancer.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Heme Oxygenase-1 and Carbon Monoxide · Metal-Catalyzed Oxygenation Mechanisms · Cancer, Hypoxia, and Metabolism
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute for Globally Distributed Open Research and Education (IGDORE) Rewari 123401 India
Department of Zoology University of Delhi Delhi 110007 India
Department of Zoology Bhaskaracharya College of Applied Sciences University of Delhi Delhi India
References (100+)
Show source-provided references
1. 10.1016/0014-5793(79)80200-810.1016/0014-5793(79)80200-8 ↗
2. 10.1016/S0021-9258(18)69078-710.1016/S0021-9258(18)69078-7 ↗
3. 10.1016/S0021-9258(17)42488-410.1016/S0021-9258(17)42488-4 ↗
4. 10.1074/jbc.272.19.1256810.1074/jbc.272.19.12568 ↗
5. 10.1111/j.1432-1033.1997.00725.x10.1111/j.1432-1033.1997.00725.x ↗
6. 10.1016/S0006-8993(02)03338-310.1016/S0006-8993(02)03338-3 ↗
7. 10.1016/j.gene.2004.04.00210.1016/j.gene.2004.04.002 ↗
8. 10.1016/0003-9861(91)90549-X10.1016/0003-9861(91)90549-X ↗
9. 10.1152/physrev.00011.200510.1152/physrev.00011.2005 ↗
10. 10.1124/pr.107.0710410.1124/pr.107.07104 ↗
11. 10.1146/annurev.pharmtox.010909.10560010.1146/annurev.pharmtox.010909.105600 ↗
12. 10.1016/j.freeradbiomed.2009.04.00710.1016/j.freeradbiomed.2009.04.007 ↗
13. 10.1016/S0002-9440(10)63365-210.1016/S0002-9440(10)63365-2 ↗
14. 10.1073/pnas.94.20.1092510.1073/pnas.94.20.10925 ↗
15. 10.1073/pnas.94.20.1091910.1073/pnas.94.20.10919 ↗
16. 10.1172/JCI616310.1172/JCI6163 ↗
17. 10.1017/S0022149X2400050610.1017/S0022149X24000506 ↗
18. 10.3390/ijms2204151410.3390/ijms22041514 ↗
19. 10.1016/j.bbrc.2005.08.02010.1016/j.bbrc.2005.08.020 ↗
20. 10.1016/S0021-9258(18)63477-510.1016/S0021-9258(18)63477-5 ↗
21. Tenhunen R. · J. Lab. Clin. Med. · 1970 · 75 · 410
22. 10.1016/j.abb.2013.10.01310.1016/j.abb.2013.10.013 ↗
23. 10.1016/S0162-0134(00)00156-210.1016/S0162-0134(00)00156-2 ↗
24. 10.1152/ajpheart.00230.201110.1152/ajpheart.00230.2011 ↗
25. 10.1084/jem.192.7.101510.1084/jem.192.7.1015 ↗
26. 10.1152/ajplung.2000.278.2.L31210.1152/ajplung.2000.278.2.L312 ↗
27. 10.1006/exnr.1997.658410.1006/exnr.1997.6584 ↗
28. 10.1002/jcp.2622310.1002/jcp.26223 ↗
29. 10.1007/s00125-014-3170-710.1007/s00125-014-3170-7 ↗
30. 10.1007/s00395-017-0603-810.1007/s00395-017-0603-8 ↗
31. 10.1186/s12958-020-00594-z10.1186/s12958-020-00594-z ↗
32. 10.1093/ajh/hpx07010.1093/ajh/hpx070 ↗
33. 10.1097/TP.000000000000220110.1097/TP.0000000000002201 ↗
34. 10.1038/ki.2010.54210.1038/ki.2010.542 ↗
35. 10.4049/jimmunol.166.6.418510.4049/jimmunol.166.6.4185 ↗
36. 10.1126/science.767835210.1126/science.7678352 ↗
37. 10.1126/science.810036810.1126/science.8100368 ↗
38. 10.1006/exnr.2001.778110.1006/exnr.2001.7781 ↗
39. 10.3390/ijms2503168010.3390/ijms25031680 ↗
40. 10.3390/cells1003051510.3390/cells10030515 ↗
41. 10.1134/S000629791606001810.1134/S0006297916060018 ↗
42. 10.1002/oby.2423610.1002/oby.24236 ↗
43. 10.3390/ijms1701013010.3390/ijms17010130 ↗
44. 10.1016/j.mex.2024.10297910.1016/j.mex.2024.102979 ↗
45. 10.1126/science.302986410.1126/science.3029864 ↗
46. 10.1073/pnas.25262699910.1073/pnas.252626999 ↗
47. 10.1089/ars.2007.180710.1089/ars.2007.1807 ↗
48. 10.3390/diseases1205010310.3390/diseases12050103 ↗
49. 10.2174/13816120878359739910.2174/138161208783597399 ↗
50. 10.1089/ars.2019.799110.1089/ars.2019.7991 ↗
51. 10.3389/fimmu.2020.0146710.3389/fimmu.2020.01467 ↗
52. 10.1006/bbrc.1996.063710.1006/bbrc.1996.0637 ↗
53. 10.1007/BF0340189710.1007/BF03401897 ↗
54. 10.1016/S0021-9258(18)83358-010.1016/S0021-9258(18)83358-0 ↗
55. 10.1111/j.1432-1033.1988.tb13811.x10.1111/j.1432-1033.1988.tb13811.x ↗
56. 10.1016/S0021-9258(18)47869-610.1016/S0021-9258(18)47869-6 ↗
57. 10.1073/pnas.86.1.9910.1073/pnas.86.1.99 ↗
58. 10.1074/jbc.273.15.892210.1074/jbc.273.15.8922 ↗
59. 10.1093/oxfordjournals.jbchem.a12315610.1093/oxfordjournals.jbchem.a123156 ↗
60. 10.1016/S0021-9258(17)31496-510.1016/S0021-9258(17)31496-5 ↗
61. 10.1016/0014-5793(89)80215-710.1016/0014-5793(89)80215-7 ↗
62. 10.1046/j.1523-1755.2001.0590041448.x10.1046/j.1523-1755.2001.0590041448.x ↗
63. 10.1111/j.1432-1033.1990.tb19263.x10.1111/j.1432-1033.1990.tb19263.x ↗
64. 10.1002/jcb.24057030610.1002/jcb.240570306 ↗
65. 10.1073/pnas.84.8.246410.1073/pnas.84.8.2464 ↗
66. 10.1042/bj339072910.1042/bj3390729 ↗
67. Marquis J. C. · Cancer Res. · 1998 · 58 · 3435
68. Naughton P. · Cell. Mol. Biol. · 2002 · 48 · 885
69. 10.1038/nm0302-24010.1038/nm0302-240 ↗
70. 10.1152/ajpcell.1998.274.4.C88310.1152/ajpcell.1998.274.4.C883 ↗
71. 10.1002/jcp.104159022110.1002/jcp.1041590221 ↗
72. 10.1152/ajplung.00151.200210.1152/ajplung.00151.2002 ↗
73. 10.1161/01.ATV.19.11.266610.1161/01.ATV.19.11.2666 ↗
74. 10.1074/jbc.M20916420010.1074/jbc.M209164200 ↗
75. 10.1210/en.2002-22061010.1210/en.2002-220610 ↗
76. Malaguarnera L. · Int. J. Mol. Med. · 2002 · 10 · 433
77. 10.1677/joe.0.180011310.1677/joe.0.1800113 ↗
78. 10.3389/fphar.2017.0014610.3389/fphar.2017.00146 ↗
79. 10.3389/fimmu.2024.137996710.3389/fimmu.2024.1379967 ↗
80. 10.1016/S0891-5849(99)00223-310.1016/S0891-5849(99)00223-3 ↗
81. 10.3389/fphar.2014.0011510.3389/fphar.2014.00115 ↗
82. 10.1182/blood.V98.6.180210.1182/blood.V98.6.1802 ↗
83. 10.1182/blood-2011-08-37530310.1182/blood-2011-08-375303 ↗
84. 10.1161/STROKEAHA.116.01560910.1161/STROKEAHA.116.015609 ↗
85. 10.1016/S0002-9440(10)65024-910.1016/S0002-9440(10)65024-9 ↗
86. 10.1186/s12931-025-03124-w10.1186/s12931-025-03124-w ↗
87. 10.1371/journal.pone.010067710.1371/journal.pone.0100677 ↗
88. 10.1096/fj.202301626RRR10.1096/fj.202301626RRR ↗
89. 10.1016/j.ijsu.2013.10.00710.1016/j.ijsu.2013.10.007 ↗
90. 10.1016/j.bcp.2018.02.01010.1016/j.bcp.2018.02.010 ↗
91. 10.1038/s41577-020-00491-x10.1038/s41577-020-00491-x ↗
92. 10.3390/antiox1103055510.3390/antiox11030555 ↗
93. 10.7717/peerj.1823710.7717/peerj.18237 ↗
94. 10.1128/microbiolspec.MCHD-0037-201610.1128/microbiolspec.MCHD-0037-2016 ↗
95. 10.1165/ajrcmb.13.4.754676810.1165/ajrcmb.13.4.7546768 ↗
96. 10.1152/ajplung.00485.200110.1152/ajplung.00485.2001 ↗
97. 10.1074/jbc.M31294120010.1074/jbc.M312941200 ↗
98. 10.1097/01.CCM.0000124869.86399.F210.1097/01.CCM.0000124869.86399.F2 ↗
99. 10.1038/s41374-019-0286-x10.1038/s41374-019-0286-x ↗
100. 10.1016/j.freeradbiomed.2021.01.02810.1016/j.freeradbiomed.2021.01.028 ↗